Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Meeting on the Mesa 2020 | Progress in the face of COVID-19

Coronavirus has impacted almost all industries. Despite this, the regenerative medicine (RegenMed) sector has shown to be incredibly resilient. Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM), Washington, DC, talks on COVID-19, and some of the issues that have arisen for RegenMed as well as positive adaptations that may remain. This interview took place during the 2020 Meeting on the Mesa congress.